Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NFX1 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | ISO | Nfx1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NFX1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | Nfx1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of NFX1 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Nfx1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFX1 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nfx1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NFX1 mRNA | CTD | PMID:21570461 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nfx1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NFX1 mRNA | CTD | PMID:15328365 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Nfx1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NFX1 mRNA | CTD | PMID:17942748 | 2-hydroxypropanoic acid | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of NFX1 mRNA | CTD | PMID:30851411 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Nfx1 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of NFX1 mRNA | CTD | PMID:18648102 | 4-hydroxynon-2-enal | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of NFX1 mRNA | CTD | PMID:12419474 | 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of NFX1 mRNA | CTD | PMID:19483382 | 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of NFX1 mRNA | CTD | PMID:19483382 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NFX1 mRNA | CTD | PMID:30047161 | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of NFX1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | NFX1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of NFX1 gene | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | NFX1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of NFX1 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of NFX1 mRNA | CTD | PMID:33167477 | amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of NFX1 mRNA | CTD | PMID:19483382 | aristolochic acid A | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of NFX1 mRNA | CTD | PMID:33212167 | benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of NFX1 mRNA | CTD | PMID:19483382 | benzo[a]pyrene | increases methylation | ISO | Nfx1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of NFX1 intron | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NFX1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | decreases expression | ISO | Nfx1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of NFX1 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of NFX1 gene | CTD | PMID:31601247 | bisphenol A | affects methylation | ISO | Nfx1 (Mus musculus) | 6480464 | bisphenol A affects the methylation of NFX1 promoter | CTD | PMID:27334623 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of NFX1 gene | CTD | PMID:28505145 | caffeine | affects phosphorylation | ISO | NFX1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of NFX1 protein | CTD | PMID:35688186 | casticin | increases expression | ISO | Nfx1 (Mus musculus) | 6480464 | casticin results in increased expression of NFX1 mRNA | CTD | PMID:28444820 | clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of NFX1 mRNA | CTD | PMID:19483382 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of NFX1 mRNA | CTD | PMID:24386269 | coumarin | affects phosphorylation | ISO | NFX1 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of NFX1 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of NFX1 mRNA | CTD | PMID:20106945 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of NFX1 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFX1 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of NFX1 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | Nfx1 (Mus musculus) | 6480464 | Ethanol affects the splicing of NFX1 mRNA | CTD | PMID:30319688 | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of NFX1 mRNA | CTD | PMID:24136188 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of NFX1 mRNA | CTD | PMID:24136188 | formaldehyde | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of NFX1 mRNA | CTD | PMID:20655997 | FR900359 | affects phosphorylation | ISO | NFX1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of NFX1 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of NFX1 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of NFX1 mRNA | CTD | PMID:22061828 | L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of NFX1 mRNA | CTD | PMID:19483382 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of NFX1 mRNA | CTD | PMID:30047161 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of NFX1 gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of NFX1 mRNA | CTD | PMID:23649840 | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of NFX1 mRNA | CTD | PMID:24136188 | omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of NFX1 mRNA | CTD | PMID:19483382 | ozone | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of NFX1 mRNA | CTD | PMID:35430440 | paracetamol | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of NFX1 mRNA | CTD | PMID:21420995 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NFX1 mRNA | CTD | PMID:32479839 | pentachlorophenol | increases expression | ISO | Nfx1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of NFX1 mRNA | CTD | PMID:23892564 | perfluorohexanesulfonic acid | decreases expression | ISO | Nfx1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of NFX1 mRNA | CTD | PMID:37995155 | phenobarbital | decreases expression | ISO | Nfx1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of NFX1 mRNA | CTD | PMID:25270620 | pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of NFX1 mRNA | CTD | PMID:19483382 | potassium chromate | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of NFX1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NFX1 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of NFX1 mRNA | CTD | PMID:30047161 | rac-lactic acid | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of NFX1 mRNA | CTD | PMID:30851411 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of NFX1 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFX1 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of NFX1 mRNA | CTD | PMID:25879800 | sodium arsenite | increases expression | ISO | NFX1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of NFX1 mRNA | CTD | PMID:12760830 | succimer | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFX1 mRNA | CTD | PMID:26378955 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of NFX1 mRNA | CTD | PMID:30047161 | thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of NFX1 mRNA | CTD | PMID:19483382 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of NFX1 mRNA | CTD | PMID:25729387 | troglitazone | decreases expression | ISO | Nfx1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of NFX1 mRNA | CTD | PMID:28973697 | valproic acid | decreases expression | ISO | NFX1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NFX1 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | NFX1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NFX1 mRNA | CTD | PMID:25979313 | vorinostat | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NFX1 mRNA | CTD | PMID:27188386 | zinc atom | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NFX1 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | NFX1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of NFX1 mRNA | CTD | PMID:18593933 | |